A trial of mass isoniazid preventive therapy for tuberculosis control.
about
Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized TrialsTuberculosis vaccines and prevention of infectionTransformative tools for tackling tuberculosisUpdates on the risk factors for latent tuberculosis reactivation and their managementsControlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionEvolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-NatalThe sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis.Update in Mycobacterium tuberculosis lung disease 2014.Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.ATS Core Curriculum 2014: part I. Adult pulmonary medicine.Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial.Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination.Advancing host-directed therapy for tuberculosis.Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners.Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach.Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.Targeting HIV services to male migrant workers in southern Africa would not reverse generalized HIV epidemics in their home communities: a mathematical modeling analysis.Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Tuberculosis prevention in South AfricaPrevalence of latent tuberculosis infection and associated risk factors in an urban African setting.Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB TestCost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.Trends in silicosis prevalence and the healthy worker effect among gold miners in South Africa: a prevalence study with follow up of employment status.Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children.Prevalence and correlates of latent tuberculosis infection among employees of a high security prison in Malaysia.Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analysesThe timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.Latent Tuberculosis in Health Care Workers Exposed to Active Tuberculosis in a Tertiary Care Hospital in OmanTuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.Transforming the fight against tuberculosis: targeting catalysts of transmission.Mycobacterium tuberculosis: 2014 Clinical trials in reviewPublic health implications of changing patterns of recruitment into the South African mining industry, 1973-2012: a database analysis.Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.Mathematical Models of Tuberculosis Reactivation and RelapseImplementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
P2860
Q26778385-E62CC05F-E57D-446F-81E2-9BFE5842CFEAQ26782022-63B1DBD0-359C-4FCB-81DF-A6B2EDDF3F69Q26784084-35D2F912-E37C-4B40-AB40-A38CE3102F77Q28073158-19FABCCE-1574-4566-8302-E43DB035059BQ28087385-CAFD30E0-777C-4A99-A120-5B647C559E0BQ28548604-512612B1-22D1-4D23-8BB9-849EBEC26780Q33656005-FE4713D1-A171-478D-9FA0-660326C927F4Q33735642-5095C9A2-445F-4A72-838A-FBC942182E3DQ33746657-4B98A911-3283-4CC4-9137-A2FB46A06AACQ33786162-A2A79645-66F7-4617-A8D1-67ACD36FAC4AQ33830371-CEE12B74-9E47-4EA2-BC87-0641747825E5Q33886920-7276EF80-D3CD-436F-81A7-484D6B75B1DDQ34466861-665A864D-8C55-45B7-ADBB-672B4B995868Q34639121-EF41F144-9EE2-4C5B-87DB-9EB603E376F3Q35127726-0B3B7B57-087E-445C-92B9-BE5671620111Q35164017-1144428E-8A13-4288-9A51-D8BF8793D825Q35197248-D5D9A527-B2C5-4AC7-B5C8-D9FF86914AE2Q35233846-8F749365-7FEA-491A-BE1E-2905B36D520CQ35297467-E39286E2-18BD-433E-851A-4A06E9FF2380Q35304473-4ABB55D0-37A6-4F46-B198-C3434092E787Q35357927-E795963C-70FA-468F-9A8C-DA84F5B71C75Q35566421-41AB2E39-F5A3-4F6C-8D5E-06453D0C124CQ35577840-92285AE8-A045-4F0A-9335-16D17F466903Q35818084-45C08229-CFAB-4298-9752-CBA27CA94276Q35873696-E79B77B3-4984-4F65-B53D-0F66E85B1C45Q36159344-66F766F0-35AB-4A51-9A96-788E350AB01BQ36223874-B46772D0-C24C-4123-B57D-C3CEFAE73DF5Q36343641-C7B2F2D1-CA46-452C-83BE-A0E1B2387E0AQ36720436-B5C70EF7-4A9F-4E07-A6F0-FE605C0F9F48Q36838289-89932FBE-D679-4A46-A2D1-5BF08A593A0DQ37053658-C50E0AE5-C3E1-4C14-9EC9-AB32A1F8AD1AQ37461120-0528BD7D-8927-4460-B1C9-BA571A1C8C41Q37514147-A6966C3C-5CBF-4268-AD06-554049BCE6DFQ37702101-C94D860E-2212-4EDA-8190-9283790878D7Q38225083-194525A4-AC6A-417F-A843-51A1D5FF51E3Q38387116-03E914EA-AEBA-4FC5-9DD3-30BF9782D254Q38399390-BC68A48E-92D7-4F5D-BEE9-9E3E13A245FDQ38805328-8584D746-F2C4-4691-9ED3-C55940E9B7F2Q38848891-7130E8C7-8C92-4DCB-B99F-805B94A351CFQ38957843-25FB9F88-1F68-470F-A9F1-3724F3AC345D
P2860
A trial of mass isoniazid preventive therapy for tuberculosis control.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A trial of mass isoniazid preventive therapy for tuberculosis control.
@en
type
label
A trial of mass isoniazid preventive therapy for tuberculosis control.
@en
prefLabel
A trial of mass isoniazid preventive therapy for tuberculosis control.
@en
P2093
P50
P356
P1476
A trial of mass isoniazid preventive therapy for tuberculosis control.
@en
P2093
Alison D Grant
Leonie Coetzee
Thibela TB Study Team
P304
P356
10.1056/NEJMOA1214289
P407
P50
P577
2014-01-01T00:00:00Z